1. Home
  2. HITI vs TVGN Comparison

HITI vs TVGN Comparison

Compare HITI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.88

Market Cap

257.8M

Sector

N/A

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$0.38

Market Cap

89.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
TVGN
Founded
2009
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
257.8M
89.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HITI
TVGN
Price
$2.88
$0.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$6.13
$5.00
AVG Volume (30 Days)
551.9K
1.4M
Earning Date
01-28-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$410,600,094.00
N/A
Revenue This Year
$14.07
N/A
Revenue Next Year
$29.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.18
N/A
52 Week Low
$1.64
$0.38
52 Week High
$4.06
$1.92

Technical Indicators

Market Signals
Indicator
HITI
TVGN
Relative Strength Index (RSI) 55.92 37.14
Support Level $2.56 $0.39
Resistance Level $2.98 $0.47
Average True Range (ATR) 0.12 0.04
MACD 0.05 0.00
Stochastic Oscillator 81.37 4.29

Price Performance

Historical Comparison
HITI
TVGN

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: